Single Microdose Trial- CXCR4 PET Tracer - Pharmacokinetics and Pharmacodynamics of [68Ga]Ga-R54, a Radiopharmaceutical Directed Toward CXCR4 in Patients With Advanced Solid Neoplasia.

NCT07577206 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

RECRUITING

Status

10

Enrollment

OTHER

Sponsor class

Conditions

Advanced Solid Tumor
Multiple Myeloma

Interventions

DRUG: [68Ga]Ga-R54 PET/CT

Sponsor

National Cancer Institute, Naples